SLC5A5 and differentiated thyroid carcinoma: The treatment effect of 211At solution in the K1-NIS xenograft model was dose-dependent and associated with prolonged survival, suggesting the potential applicability of targeted α-therapy for the treatment of advanced differentiated thyroid cancer.